Home About News

Get in Touch

Welcome

Turn GPCR Chaos Into Insights

Expert strategic and scientific consultancy to accelerate your pipeline

Book My Consultation

Critical Bottlenecks in Your GPCR Pipeline

❌ Overwhelming pharmacology Data

❌ Suboptimal CRO Partnerships

❌ Stalled Pipeline Progression

❌ Uncertainty in GPCR Investments

Advisory Focus Areas

Expert support for Biotech innovators, VC investors and CRO partners

20250429_1318_Rocket-Powered Growth_remix_01jt18w8awezq8xxtbydadrnpz.png

Biotech Pipeline Acceleration

For Biotech Leaders & Scientists

Actionable Data Insights: Translate complex GPCR pharmacology into clear decisions for lead optimization and candidate selection.
Accelerated Program Progression: Design robust assay cascades and establish key go/no-go points to speed up your pipeline.
Optimized CRO Collaboration: Streamline internal R&D and external CRO workflows to prevent delays and ensure preclinical success.

Fuel Discovery

20250429_1202_Smaller Building, More Space_remix_01jt14grv0fgn8hgg66set6rvx.png

VC Due Diligence & De-risking

For Venture Capital Firms

De-risk GPCR Investments: Identify critical scientific red flags and technical gaps in GPCR assets before committing capital.
Actionable Scientific Validation: Ensure target companies execute the right GPCR pharmacology experiments to generate robust, decision-making data.
Clear Platform Assessment: Gain rapid, independent insight into GPCR platform risks and true therapeutic potential to inform investment strategy.

Fast-Track Discovery

20250429_1634_Collaborative Science Puzzle_remix_01jt1m2z19eantkgpn8egkw689.png

CRO Partnership & Optimization

For Contract Research Organizations

Elevate Scientific Offerings: Refine and optimize your GPCR assay platforms and in vitro models to deliver superior data quality and results.
Enhance Client Project Delivery: Streamline workflows and improve scientific execution to increase client satisfaction and secure repeat business.
Differentiate Your Market Position: Showcase your specialized GPCR expertise to stand out from competitors and attract high-value biotech and pharma partners.

Power Discovery

How We Work: Your Path to GPCR Success

Initial Strategic Alignment

We begin with a focused discussion of your current GPCR program and critical challenges, identifying precise areas for collaboration.

Define Actionable Objectives

Together, we clarify specific, measurable goals, from target validation and assay development to CRO selection or portfolio strategy, ensuring a tailored approach.

Collaborative Execution & Impact

I integrate directly into your discovery process to remove roadblocks, enhance execution, and generate actionable scientific data, driving confident decisions and sustained preclinical progress.

Advance My Discovery

My Approach: Precision Guidance for GPCR Programs

I provide the focused, scientific expertise that accelerates complex GPCR discovery programs, ensuring clarity and de-risking your path from target to candidate. I integrate seamlessly with biotech, VC, and CRO teams as a trusted, objective partner.

Integrated Strategic Partnership

We collaborate directly with your scientific and leadership teams. This partnership prevents bottlenecks and optimizes resource allocation, ensuring every strategic decision efficiently propels your program forward and aligns with critical business objectives.

Biology-First, Data-Driven Solutions

Every recommendation is rooted in GPCR biology, pharmacology experience. This provides evidence-based strategies leveraging deep GPCR expertise to overcome specific scientific challenges and maximize your program's potential.

Accelerated Preclinical Progression

I streamline critical operational processes, from advanced assay design and CRO management to rapid go/no-go decision-making. This focused execution accelerates preclinical milestones and maximizes the efficiency and return on your R&D investment.

Core Values: The Foundation of Every Successful Partnership

My advisory is built on principles that ensure clarity, minimize risk, and drive enduring results in GPCR drug discovery.

Scientific Integrity

Every recommendation is rigorously evidence-based, not reliant on assumptions. This ensures robust, defensible decisions that de-risk your program from early discovery to regulatory milestones.

Operational Discipline

I instill structure and consistency across every phase of your discovery process. This approach eliminates inefficiencies and standardizes workflows, accelerating your path to a preclinical candidate.

Collaborative Partnership

I operate as an embedded, invested partner with your team. Your program's success is my priority, fostering a transparent, results-driven environment that maximizes collective expertise and accelerates progress.

About Yamina A. Berchiche

I'm Yamina A. Berchiche, and I understand the intricate challenges of GPCR drug discovery. Small missteps can derail entire programs: underperforming assays, off-track CROs, and data that fails to drive decisions. That's precisely where my expertise becomes your strategic advantage.

With over two decades dedicated to GPCR pharmacology across biotech, academia, and the non-profit sector, I bring unparalleled scientific depth and operational precision to every project. My work focuses on integrating directly with your team as a strategic partner.

Whether it's optimizing CRO selection, building robust internal capabilities, or translating complex data into decisive program advancements, I help you eliminate friction, align efforts, and accelerate your path to success.

As the founder of Dr. GPCR, I also offer a unique, broad perspective and trusted relationships within the field. This allows me to connect you with critical insights and key collaborators, further accelerating your progress in GPCR drug discovery.

Let's Talk Discovery

What Partners Say

Here’s what it’s like to work together — from people I’ve supported on both sides of the bench.

Anne Marie Quinn, CEO
Montana Molecular

Before working with Yamina, we were generating high-quality data across biotech programs but often navigating evolving expectations and goals from different stakeholders.

After partnering with her, communication became clearer, deliverables were better defined, and collaboration across teams ran more smoothly.

She helped streamline complex projects and made the CRO–client relationship more effective and productive.

Terry Kenakin, PhD
UNC Chappel Hill

Yamina brings scientific clarity, leadership, and precision execution to complex pharmacological programs.

I’ve worked with her on several discovery programs; in fragmented programs she bought clarity and decision points that produced much better candidate progression.

I am always delighted to work with Yamina as it always leads to an overall better and harmonious discovery program.

Murat Tunaboylu, CEO
Antiverse

Before engaging Yamina, our team faced hurdles in navigating complex early discovery decisions. We had critical program choices ahead and needed clear direction.

Bringing her in was a turning point. We swiftly made confident progress on a pivotal program and gained absolute clarity on our next strategic focus.

Yamina was instrumental in unifying our scientific and operational teams, fostering crucial alignment and driving decisive momentum across every aspect of execution.

Book

Book My 30 Minutes Strategy Call

Ready to collaborate?

Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution across biotech, VC, and CRO teams.

Get in touch

Connect

Proudly created with Wix.com